MedPath

MORPHINE SPARING EFFECT OF INTERMITTENT VERSUS CONTINUOUS INTRAVENOUS INFUSION OF NEFOPAM IN PATIENTS AFTER TOTAL KNEE ARTHROPLASTY

Phase 4
Recruiting
Conditions
unilateral primary gonarthrosis
osteoarthritis, total knee arthroplasty, Nefopam, morphine sparing effect
Registration Number
TCTR202103160010
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
144
Inclusion Criteria

1. age 18 years and above
2. undergoing primary unilateral total knee arthroplasty
3. weight at least 45 kilograms

Exclusion Criteria

1. patients with seizure or have history of seizure
2. patients with benign prostatic hypertrophy or abnormality of urinary tract
3. close angle glaucoma
4. cardiovascular and cerebrovascular disease
5. creatinine clearance less than 30 ml/min
6. impaired hepatic function
7. have current medications in SSRI, SNRI and TCA
8. psychiatric patients
9. have underlying disease involve abnormality of spine and hip
10. intra-operative complications
11. denied morphine use
12. allergic to any medications in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
morphine consumption at 48 hours milligrams
Secondary Outcome Measures
NameTimeMethod
pain score at rest every 4 hours numeric rating scale,adveres drug reactions during study peroid nurse record
© Copyright 2025. All Rights Reserved by MedPath